2024 News Release

NHI Drug Price Revision for Fiscal 2025 (FY2025)

Participation in the "Pharmaceutical Visionary Conference 2024
Toward Dialogue and Co-creation among Diverse Stakeholders

Joint Statement by the Three Pharmaceutical Organizations of Japan, the U.S. and Europe
Opinion on the Fiscal 2025 Mid-Year NHI Price Revision and National Strategy

Survey on the Problems of Healthcare Professionals in Rare Diseases

Announcement of the Pharmaceutical Association of Japan Code of Practice "Month for Promoting Understanding of the Code

Material for the Pharmaceutical Manufacturers Association of Japan (PMAJ) Chairman's Press Conference held on October 8

The Pharmaceutical Manufacturers Association of Japan (PMAJ) 2nd (FY2024) "Open Call for Researcher Support and Grant

Approaches to Eliminate Drug Losses" proposed by the MHLW's Study Council on Unapproved and Off-label Drugs of High Medical Need

"The 13th Asian Pharmaceutical Manufacturers' Association Conference" held on

13th Asian Pharmaceutical Association Conference (APAC) Press Conference held on April 24

Educational Event in the Pharmaceutical and Medical Fields "Living with Disease. Living with Hope. Photo Exhibition: "Living with Disease: To the Future that Produces Unseen Answers," the Second Event to be Held in Osaka

Press Conference by the Chairman of the Pharmaceutical Manufacturers Association of Japan (PMAJ) held on February 15, 2011